Literature DB >> 15347994

Biodegradable tube implants in experimental glaucoma surgery in the rabbit.

M Kivalo1, V Siren, C Raitta, I Immonen.   

Abstract

Although ocular drainage implants are manufactured from biocombatible materials to reduce foreign-body reaction, the formation of excessive scar tissue around the implant is a common cause for implant failure. In this study, the suitability of poly(D, L-lactide-co-glycolide) copolymer, impregnated with an antiproliferative agent retinoic acid, was evaluated as a material for biodegradable tubular implants, as well as the duration and magnitude of the intraocular pressure reduction obtained with the prototype implant. Subconjunctivally placed retinoid-impregnated polymer particles caused a milder inflammatory reaction than plain polymer, and the layer of connective tissue around the material was thinner after the follow-up period of 60 d. In the anterior chamber, the inflammatory response elicited by the material was milder than subconjunctivally. The plain polymer caused a transiently stronger reaction than the retinoid-impregnated polymer, but after 60 d no difference was evident between the two materials. In all operated eyes with the tubular implant, the intraocular pressure was statistically significantly lower (p<0.05) than in control eyes for 9 wk after the operation. The intraocular pressure of the eyes with the retinoid-impregnated implant was statistically significantly lower (p<0.05) than in eyes with a plain polymer implant for up to 7 wk post-operatively. However, the use of retinoid did not prolong the effective functioning time of the implants. Copyright 1999 Kluwer Academic Publishers

Entities:  

Year:  1999        PMID: 15347994     DOI: 10.1023/a:1008896211886

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  29 in total

1.  Long tube implants in the management of glaucoma.

Authors:  A C Molteno; J L Straughan; E Ancker
Journal:  S Afr Med J       Date:  1976-06-26

2.  Control of bleb fibrosis after glaucoma surgery by anti-inflammatory agents.

Authors:  A C Molteno; J L Straughan; E Ancker
Journal:  S Afr Med J       Date:  1976-05-29

3.  Fracture reduction using a biodegradable material, polylactic acid.

Authors:  D E Cutright; E E Hunsuck; J D Beasley
Journal:  J Oral Surg       Date:  1971-06

4.  Modulation of procollagen gene expression by retinoids. Inhibition of collagen production by retinoic acid accompanied by reduced type I procollagen messenger ribonucleic acid levels in human skin fibroblast cultures.

Authors:  H Oikarinen; A I Oikarinen; E M Tan; R P Abergel; C A Meeker; M L Chu; D J Prockop; J Uitto
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

5.  Retinoic acid inhibition of transforming growth factor-beta-induced collagen production by human lung fibroblasts.

Authors:  C A Redlich; H M Delisser; J A Elias
Journal:  Am J Respir Cell Mol Biol       Date:  1995-03       Impact factor: 6.914

6.  Wound healing after filtering surgery in owl monkeys.

Authors:  D C Desjardins; R K Parrish; R Folberg; J Nevarez; D K Heuer; M G Gressel
Journal:  Arch Ophthalmol       Date:  1986-12

7.  5-fluorouracil and glaucoma filtering surgery: I. An animal model.

Authors:  M G Gressel; R K Parrish; R Folberg
Journal:  Ophthalmology       Date:  1984-04       Impact factor: 12.079

8.  Pharmacokinetics of etoposide delivery by a bioerodible drug carrier implanted at glaucoma surgery.

Authors:  P Uppal; H D Jampel; H A Quigley; K W Leong
Journal:  J Ocul Pharmacol       Date:  1994

9.  Subconjunctival high dose plasminogen activator in rabbit filtration surgery.

Authors:  G H Strauss; E T Dunn; R C Dunn; G B Bodiford; J Christie
Journal:  J Ocul Pharmacol       Date:  1991

10.  Glaucoma filtration surgery in rabbits using bioerodible polymers and 5-fluorouracil.

Authors:  D A Lee; R A Flores; P J Anderson; K W Leong; C Teekhasaenee; A W de Kater; E Hertzmark
Journal:  Ophthalmology       Date:  1987-12       Impact factor: 12.079

View more
  1 in total

1.  In vivo biocompatibility assessment of (PTFE-PVDF-PP) terpolymer-based membrane with potential application for glaucoma treatment.

Authors:  Rafał Leszczynski; Ewa Stodolak; Jarosław Wieczorek; Jolanta Orlowska-Heitzman; Teresa Gumula; Stanislaw Blazewicz
Journal:  J Mater Sci Mater Med       Date:  2010-07-23       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.